Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
John Stansel is an analyst at JP Morgan. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/25/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/17/2024 | MOH | Buy Now | Molina Healthcare | $310.53 | 12.71% | John Stansel66% | $378 → $350 | Assumes | Overweight → Neutral | Get Alert |
| 12/17/2024 | CNC | Buy Now | Centene | $58.94 | 27.25% | John Stansel66% | $80 → $75 | Assumes | Neutral → Overweight | Get Alert |
| 11/17/2023 | DGX | Buy Now | Quest Diagnostics | $165.00 | -9.7% | John Stansel66% | $148 → $149 | Maintains | Neutral | Get Alert |
| 11/17/2023 | LH | Buy Now | Laboratory Corp | $234.45 | 11.32% | John Stansel66% | $259 → $261 | Maintains | Overweight | Get Alert |
| 04/19/2022 | ONON | Buy Now | On Holding | $48.01 | -35.43% | John Stansel66% | → $31 | Initiates | → Buy | Get Alert |
